> Details

Tomanoski, Vasilije; Gjorgjievska, Gordana; Zvezdakovska, Jasminka; Krecova, Vasiliki; Andonoski, Aleksandar; Nakovska, Margarita; Muharemi, Serjat; Kliseski, Tode; Janakievska, Pavlina; Ristoska, Katerina; Veliu, Ramazan; Vasileva, Liljana; Jovanov, Toni; Mehmedi-Veseli, Kaltrina; Ferati, Beane; Sterjovska, Jasmina; Kepeska, Sintia; Kachakova, Angela

The Determinants of Hemoglobin Variability in Hemodialysis Patients

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: The Determinants of Hemoglobin Variability in Hemodialysis Patients
  • Contributor: Tomanoski, Vasilije; Gjorgjievska, Gordana; Zvezdakovska, Jasminka; Krecova, Vasiliki; Andonoski, Aleksandar; Nakovska, Margarita; Muharemi, Serjat; Kliseski, Tode; Janakievska, Pavlina; Ristoska, Katerina; Veliu, Ramazan; Vasileva, Liljana; Jovanov, Toni; Mehmedi-Veseli, Kaltrina; Ferati, Beane; Sterjovska, Jasmina; Kepeska, Sintia; Kachakova, Angela
  • imprint: Walter de Gruyter GmbH, 2016
  • Published in: BANTAO Journal
  • Language: English
  • DOI: 10.1515/bj-2016-0019
  • ISSN: 2451-3105
  • Keywords: Transplantation ; Nephrology
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title> <jats:p> Introduction. Factors that have been reported to affect erythropoietin (EPO) responsiveness in hemodialysis (HD) patients include iron deficiency, chronic inflammation, secondary hyperparathyroidism, malnutrition and inadequate HD dose. The aim of the study was to analyze the deteminants of hemoglobin variability in HD patients. Methods. The study encompassed 526 patients (197 F and 329 M). According to HD vintage at the beginning of the study the patients were divided into two groups: group-1 encompassed 153 patients with HD vintage bellow 24 months, and group-2 encompassed 329 patients with HD vintage over 24 months. Over a period of 21 months after admission the following parameters were analyzed: hemoglobin (Hb), EPO dose, iron dose, HD dose (eKT/V), transferrin saturation (TSAT), C-reactive protein (CRP), ferritin and serum albumin at 3 months and parathyroid hormone (PTH) at 6 months. Results. The percentage of patients with Hb&gt;=105g/L significantly improved, and the average Hb level significantly increased in both groups over a period of 21 months. The average EPO and iron dose significantly decreased, but TSAT and ferritin levels significantly increased over a period of 21 months. The average eKT/V and s-albumin values significantly increased, but the average CRP and PTH levels significantly decresead over a period of 21 months. In group-1 EPO dose and CRP, but in group-2 EPO dose, ferritin, HD vintage, and iron dose were statistically significant predictors of the Hb level 9 months after admission. Conclusions. Insufficient EPO therapy, iron deficiency and chronic inflammation were the main factors of inadequate correction of anemia in HD patients before admission.</jats:p>
  • Access State: Open Access